FEATURES OF CHANGES IN THE HEMOSTASIS SYSTEM IN PATIENTS WITH COVID-19 SARS-COV-2 INFECTION
DOI:
https://doi.org/10.17605/OSF.IO/ZFYHXKeywords:
COVID-19, SARS-CoV-2, thrombotic thromboembolic complications, venous and arterial thrombosisAbstract
Coronavirus infection (COVID-19) is an acute infectious disease caused by the SARS-CoV-2 virus and characterized by activation of the hemostasis system. As a result of this, severe conditions can develop, i.e. coagulopathy. It remains unclear whether COVID-19 is the direct cause of these conditions or whether they occur during the development of an infectious process. The incidence of asymptomatic and clinically evident thrombotic thromboembolic complications in COVID-19 remains unclear. This situation is largely due to the difficulties of diagnosis. However, according to some reports, the frequency of venous and arterial thrombosis in patients with COVID-19 is significantly higher. At the same time, the features of the course of the disease aroused interest in terms of searching and studying its causing factors and caused a lot of discussion.